The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

James K. Hennan

Cardiovascular and Metabolic Disease Research

Collegeville

Pennsylvania

USA

[email]@wyeth.com

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Cardiovascular and Metabolic Disease Research, Collegeville, Pennsylvania, USA. 2005 - 2009
  • Wyeth Research, Philadelphia, PA 19101. 2006
  • Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Mich., USA. 2006

References

  1. GAP-134 ([2S,4R]-1-[2-aminoacetyl]4-benzamidopyrrolidine-2-carboxylic acid) prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia/reperfusion injury in open-chest dogs. Hennan, J.K., Swillo, R.E., Morgan, G.A., Rossman, E.I., Kantrowitz, J., Butera, J., Petersen, J.S., Gardell, S.J., Vlasuk, G.P. J. Cardiovasc. Pharmacol. Ther. (2009) [Pubmed]
  2. Effect of tiplaxtinin (PAI-039), an orally bioavailable PAI-1 antagonist, in a rat model of thrombosis. Hennan, J.K., Morgan, G.A., Swillo, R.E., Antrilli, T.M., Mugford, C., Vlasuk, G.P., Gardell, S.J., Crandall, D.L. J. Thromb. Haemost. (2008) [Pubmed]
  3. Rotigaptide (ZP123) prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia/reperfusion injury in open-chest dogs. Hennan, J.K., Swillo, R.E., Morgan, G.A., Keith, J.C., Schaub, R.G., Smith, R.P., Feldman, H.S., Haugan, K., Kantrowitz, J., Wang, P.J., Abu-Qare, A., Butera, J., Larsen, B.D., Crandall, D.L. J. Pharmacol. Exp. Ther. (2006) [Pubmed]
  4. Pharmacologic inhibition of platelet vWF-GPIb alpha interaction prevents coronary artery thrombosis. Hennan, J.K., Swillo, R.E., Morgan, G.A., Leik, C.E., Brooks, J.M., Shaw, G.D., Schaub, R.G., Crandall, D.L., Vlasuk, G.P. Thromb. Haemost. (2006) [Pubmed]
  5. Effect of sodium/hydrogen exchange inhibition on myocardial infarct size after coronary artery thrombosis and thrombolysis. Hennan, J.K., Driscoll, E.M., Barrett, T.D., Fischbach, P.S., Lucchesi, B.R. Pharmacology (2006) [Pubmed]
  6. Evaluation of PAI-039 [{1-benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid], a novel plasminogen activator inhibitor-1 inhibitor, in a canine model of coronary artery thrombosis. Hennan, J.K., Elokdah, H., Leal, M., Ji, A., Friedrichs, G.S., Morgan, G.A., Swillo, R.E., Antrilli, T.M., Hreha, A., Crandall, D.L. J. Pharmacol. Exp. Ther. (2005) [Pubmed]
 
WikiGenes - Universities